Clinical Trial

Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 17, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluating the Safety and Efficacy of Sirolimus-coated Coronary Balloon Dilatation Catheter vs Paclitaxel-coated balloon catheter for the Treatment of De Novo Coronary Bifurcation Lesions
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-06.
Status change: Not Yet Recruiting → Recruiting 2025-09-11
Trial Details
NCT Number NCT06822712
Lead Sponsor BrosMed Medical Co., Ltd
Collaborators: LanZhou University
Conditions Coronary Arterial Disease (CAD)
Enrollment 250 participants
Start Date 2025-03-03
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-17